LDC3140
LDC3140 is a selective CDK7 inhibitor (IC50CDK7, LDC3140 affects the regulation of the cell cycle, leading to cell cycle arrest and thus inhibiting the proliferation of tumor cells. LDC3140 can be used in the research of cancer treatment[1].
Product Specifications
CAS Number
[1453833-30-1]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ldc3140.html
Smiles
CC(C)C1=C2N=C(OC3CCN(C)CC3)N=C(NCC4=CC=CC=C4N(C)C)N2N=C1
Molecular Formula
C23H33N7O
Molecular Weight
423.55
References & Citations
[1]H Liang, et al. Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy. Expert Opinion on Investigational Drugs 30.1 (2021) : 61-76.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
